292 related articles for article (PubMed ID: 20856196)
21. Dual regulatory roles of human AP-endonuclease (APE1/Ref-1) in CDKN1A/p21 expression.
Sengupta S; Mitra S; Bhakat KK
PLoS One; 2013; 8(7):e68467. PubMed ID: 23874636
[TBL] [Abstract][Full Text] [Related]
22. Regulation of limited N-terminal proteolysis of APE1 in tumor via acetylation and its role in cell proliferation.
Bhakat KK; Sengupta S; Adeniyi VF; Roychoudhury S; Nath S; Bellot LJ; Feng D; Mantha AK; Sinha M; Qiu S; Luxon BA
Oncotarget; 2016 Apr; 7(16):22590-604. PubMed ID: 26981776
[TBL] [Abstract][Full Text] [Related]
23. Endogenous oxidized DNA bases and APE1 regulate the formation of G-quadruplex structures in the genome.
Roychoudhury S; Pramanik S; Harris HL; Tarpley M; Sarkar A; Spagnol G; Sorgen PL; Chowdhury D; Band V; Klinkebiel D; Bhakat KK
Proc Natl Acad Sci U S A; 2020 May; 117(21):11409-11420. PubMed ID: 32404420
[TBL] [Abstract][Full Text] [Related]
24. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
25. Essential role for mammalian apurinic/apyrimidinic (AP) endonuclease Ape1/Ref-1 in telomere maintenance.
Madlener S; Ströbel T; Vose S; Saydam O; Price BD; Demple B; Saydam N
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17844-9. PubMed ID: 24127576
[TBL] [Abstract][Full Text] [Related]
26. The role of the N-terminal domain of human apurinic/apyrimidinic endonuclease 1, APE1, in DNA glycosylase stimulation.
Kladova OA; Bazlekowa-Karaban M; Baconnais S; Piétrement O; Ishchenko AA; Matkarimov BT; Iakovlev DA; Vasenko A; Fedorova OS; Le Cam E; Tudek B; Kuznetsov NA; Saparbaev M
DNA Repair (Amst); 2018 Apr; 64():10-25. PubMed ID: 29475157
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
28. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells.
Daschner PJ; Ciolino HP; Plouzek CA; Yeh GC
Breast Cancer Res Treat; 1999 Feb; 53(3):229-40. PubMed ID: 10369069
[TBL] [Abstract][Full Text] [Related]
29. Fine-tuning of DNA base excision/strand break repair via acetylation.
Bhakat KK; Sengupta S; Mitra S
DNA Repair (Amst); 2020 Sep; 93():102931. PubMed ID: 33087268
[TBL] [Abstract][Full Text] [Related]
30. Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters.
Stein U; Jürchott K; Walther W; Bergmann S; Schlag PM; Royer HD
J Biol Chem; 2001 Jul; 276(30):28562-9. PubMed ID: 11369762
[TBL] [Abstract][Full Text] [Related]
31. SIRT1 gene expression upon genotoxic damage is regulated by APE1 through nCaRE-promoter elements.
Antoniali G; Lirussi L; D'Ambrosio C; Dal Piaz F; Vascotto C; Casarano E; Marasco D; Scaloni A; Fogolari F; Tell G
Mol Biol Cell; 2014 Feb; 25(4):532-47. PubMed ID: 24356447
[TBL] [Abstract][Full Text] [Related]
32. Human AP endonuclease/redox factor APE1/ref-1 modulates mitochondrial function after oxidative stress by regulating the transcriptional activity of NRF1.
Li M; Vascotto C; Xu S; Dai N; Qing Y; Zhong Z; Tell G; Wang D
Free Radic Biol Med; 2012 Jul; 53(2):237-48. PubMed ID: 22580151
[TBL] [Abstract][Full Text] [Related]
33. Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells.
Pan ST; Zhou J; Yang F; Zhou SF; Ren T
BMC Cancer; 2020 Jul; 20(1):634. PubMed ID: 32641008
[TBL] [Abstract][Full Text] [Related]
34. Lysine acetyltransferases cyclic adenosine monophosphate response element-binding binding protein and acetyltransferase p300 attenuate transcriptional activity of the mineralocorticoid receptor through its acetylation.
Seo M; Song M; Seok YM; Kang SH; Lee HA; Sohn UD; Kim IK
Clin Exp Pharmacol Physiol; 2015 May; 42(5):559-66. PubMed ID: 25707758
[TBL] [Abstract][Full Text] [Related]
35. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
[TBL] [Abstract][Full Text] [Related]
36. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies.
Kuwano M; Uchiumi T; Hayakawa H; Ono M; Wada M; Izumi H; Kohno K
Cancer Sci; 2003 Jan; 94(1):9-14. PubMed ID: 12708467
[TBL] [Abstract][Full Text] [Related]
37. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of Pol III-dependent 5S rRNA and U6 snRNA gene expression by AP-1 transcription factors.
Ahuja R; Kumar V
FEBS J; 2017 Jul; 284(13):2066-2077. PubMed ID: 28488757
[TBL] [Abstract][Full Text] [Related]
39. Nucleolar accumulation of APE1 depends on charged lysine residues that undergo acetylation upon genotoxic stress and modulate its BER activity in cells.
Lirussi L; Antoniali G; Vascotto C; D'Ambrosio C; Poletto M; Romanello M; Marasco D; Leone M; Quadrifoglio F; Bhakat KK; Scaloni A; Tell G
Mol Biol Cell; 2012 Oct; 23(20):4079-96. PubMed ID: 22918947
[TBL] [Abstract][Full Text] [Related]
40. Small molecule activation of apurinic/apyrimidinic endonuclease 1 reduces DNA damage induced by cisplatin in cultured sensory neurons.
Georgiadis MM; Chen Q; Meng J; Guo C; Wireman R; Reed A; Vasko MR; Kelley MR
DNA Repair (Amst); 2016 May; 41():32-41. PubMed ID: 27078577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]